Asinidobacter: A Drug That Might Actually Be Effective

In the credible study which of course evaluated it's a fitter recall for the treatment of patients with carbapenemarzisin infections end of study mortality was 34% for sifidiracal treated patients and 18% in the best available therapy arm. So what we have is non-inferiority and numerically higher clinical cure with solder compared to Callistin based combinations. And then importantly superiority in terms of safety way less nephrotoxicity they also did present a couple of posters where they looked at solder in combination with emi penum and with myro penum and hollow fiber mollows hollow fiber models. We might finally have a drug that works

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app